Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms 40 Rectal Neoplasms 21 Colorectal Neoplasms 20 Colonic Neoplasms 19 Glioblastoma 13 Pancreatic Neoplasms 12 Carcinoma, Non-Small-Cell Lung 12 Stomach Neoplasms 11 Gliosarcoma 11 Central Nervous System Neoplasms 11 Esophageal Neoplasms 9 Prostatic Neoplasms 8 Lung Neoplasms 8 Head and Neck Neoplasms 8 Uterine Cervical Neoplasms 7 Carcinoma, Intraductal, Noninfiltrating 7 Adenocarcinoma Of Esophagus 7 Squamous Cell Carcinoma of Head and Neck 6 Sarcoma 6 Ovarian Neoplasms 6 Neoplasm Metastasis 6 Carcinoma, Ovarian Epithelial 6 Breast Neoplasms, Male 6 Melanoma 5 Esophageal Squamous Cell Carcinoma 5 Breast Carcinoma In Situ 5 Salivary Gland Neoplasms 4 Nasopharyngeal Carcinoma 4 Lymphoma 4 Fallopian Tube Neoplasms 4

Interventions

ribociclib 1 Tretinoin 1 Letrozole 1 Goserelin 1 Drug Therapy 1 Chemotherapy, Adjuvant 1 Anastrozole 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

OTHER × HER2 Negative Breast Cancer × Chemotherapy, Adjuvant × Clear all

NCT06953882 2026-05-26

SELECT

Yale University

Phase 2 Recruiting

HER2 Negative Breast Cancer

Data powered by HemOnc (CC BY 4.0) Colophon ⚡